Research Article

Prognosis and Major Events During Follow-up of Asymptomatic Hepatitis B Surface Antigen (HBsAG) Carries

Ocular Findings Before and After Pegylated Interferon Treatment in Chronic Hepatitis B and C Patients

• Şükran KÖSE
• Melda TÜRKEN
• Lütfiye KUZUCU
• Gamze TÜRE
• Tümay ÖRSEL

The Relationship Between the Methods of Male Circumcision Procedures Used in the Past and the Prevalence of Viral Hepatitis

• Selma TOSUN
• İsmail BALIK
• Neşe İNAN
• Nese SALTOĞLU
• Necati ÖRMECİ
• İrfan ŞENCAN
• Fehmi TABAK

Interleukin 10 (IL-10) Cytokine Polymorphism in Patients with Chronic Hepatitis B and in Asymptomatic Hepatitis B Carriers

• Handan CEBECİ
• Mehmet SÖKMEN
• Nurgül CEREN
• Rıza ADALETİ
• E. Çiğdem KASPAR
• May KORACHİ

Long-term Sustained Virological Response Rate in Treatment of Chronic Hepatitis C Patients

• Mustafa SÜNBÜL
• Tuba KURUOĞLU
• İsmail Hakkı DÜNDAR
• Şaban ESEN
• Cafer EROĞLU
• Hakan LEBLEBİCİOĞLU

Seroprevalence of Hepatitis B Surface Antigen, Anti-Hepatitis B Surface and Anti-Hepatitis C Virus Among Pregnant Women Residing in Şırnak Province

• Meyha ŞAHİN
• Meltem ZENCİR
• Alper Akın GÖZÜBÜYÜK
• Bedri Aras PEKTAŞ

Performance of Rapid Test in Detection of Anti-HCV in Frozen Sera

• Zafer MENGELOĞLU
• Özlem BUCAK
• Esra KOÇOĞLU
• Tekin TAŞ
• Şeyda KARABÖRK

A Comparison of Interferon α-2a Plus Ribavirin Combination Therapy with Peginterferon α-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C

• Hayati DEMİRASLAN
• Bilgehan AYGEN
• Orhan YILDIZ
• Işın SOYUER
• Selma GÖKAHMETOĞLU

IFN-a2b Induction Treatment with Ribavirin in Patients with Chronic Hepatitis C

• Yunus GÜRBÜZ
• Ediz TÜTÜNCÜ
• Ruçhan TÜRKYILMAZ

Hepatitis B and Hepatitis C Seropositivities in Women Admitted To Gynecology and Obstetrics Hospital in Şanlıurfa City: A 3- Year Evaluation

• Ayşegül ÇOPUR ÇİÇEK
• İbrahim Halil İNAKÇI
• Fazilet DUYGU

The Role of the Basal Core Promoter (BCP) and Precore Codon 28 Mutations in the Treatment Response to the Pegylated Interferon

• Şükran KÖSE
• Süheyla Serin SENGER
• Gülsün ÇAVDAR
• Pelin ADAR

Evaluation of the Knowledge on Viral Hepatitis of General Practitioners in the City Center of , Şanlıurfa

• Süda TEKİN KORUK
• Zühre ALPUA
• İbrahim KORUK

Seropositivity Rates of HBsAg, Anti-HCV and Anti-HIV in Blood Donors in Düzce Area

• Şükrü ÖKSÜZ
• Mustafa YILDIRIM
• Çiğdem ÖZAYDIN
• İrfan ŞENCAN

Hepatitis C Virus Genotyping by Using Restriction Fragment Length Polymorphism (RFLP) in Anti-HCV Positive Hemodialysis Patients and Renal Transplant Recipients

The Long Term Follow-up Results of Chronic Hepatitis B Cases: Cerrahpasa Experience

• Fehmi TABAK
• Ömür TABAK
• Resat ÖZARAS
• Ali MERT
• Hakan SENTÜRK

TNF-alpha 308 SNP Rs3091256 GG Genotype is Strongly Associated with Fibrosis in Patients with Chronic Hepatitis C

• Özgür GÜNAL
• Didem YALÇIN
• Betül ÇELİK
• Aydın RÜSTEMOĞLU
• Osman DEMİR
• Şener BARUT
• Ömer ATEŞ
• Sırrı KILIÇ

The Evaluation of the Side Effects of Pegilated Interferon Monotherapy and Pegilated Interferon /Lamivudin Treatment in Patients With Chronic Hepatitis B

• Kutbettin DEMİRDAĞ
• Gülden ESER KARLIDAĞ

Can HBsAg Be Used as a Viral Replication Marker in Chronic Hepatitis B Patients?

• Emel UZUNOĞLU
• Ahmet Melih ŞAHİN
• Esin AVCI
• Hakan KUTLU
• Gökçe GÜNTEPE

Evaluation of 1380 Percutaneous Blind Liver Needle Biopsies Performed in Patients With Chronic Viral Hepatitis

• Vedat TURHAN
• Ali ACAR
• Zafer KÜÇÜKODACI
• Mehmet ÇOBAN
• Zehra KARACAER
• Sinem BUDAK
• Hüsrev DİKTAŞ
• Ercan YENİLMEZ
• Kenan ARICAN
• Oral ÖNCÜL
• Levent GÖRENEK

Relationship between HBV-DNA Level and Treatment Success in HBeAg Negative Patients Treated with Pegylated Interferone

• Ertuğrul GÜÇLÜ
• Nazan TUNA
• Mehmet YAHYAOĞLU
• Oğuz KARABAY

The Effectivity of Combination of Standard Interferon-a + Ribavirin and Pegylated Interferon-a + Ribavirin Therapy in Patients with Chronic Hepatitis C

• Nail ÖZGÜNES
• Fatma SARGIN
• Saadet YAZICI
• Nüket CEYLAN
• Ayse Canan ÜÇISIK
• Pinar ERGEN
• Arzu DOGRU
• Özlem AYDIN

Evaluation of Hepatitis C Patients in Şanlıurfa Region

• Haşim NAR
• Ahmet UYANIKOĞLU
• Timuçin AYDOĞAN
• Necati YENİCE

Diagnosis of Hepatitis C Infection in Turkey: How Can Serology be Helpful?

• Kemal Osman MEMIKOGLU
• Hakan ARABACI
• Alpay AZAP
• Aysegül YESILKAYA
• Serhat BIRENGEL
• Ismail BALIK

The Evaluation of Pegylated Interferon Therapy in Patients with Chronic Hepatitis Delta

• Ayşe ALBAYRAK
• Muharrem COŞKUN
• Ahmet UYANIKOĞLU
• Yasin BAYIR
• Havva YILMAZ
• Yunus İlyas KİBAR
• Ahmet TAY
• Fatih ALBAYRAK

Evaluation of 219 Patients with Chronic Hepatitis C Receiving Pegylated Interferon + Ribavirin Treatment

• Nevil AYKIN
• Figen ÇAĞLAN ÇEVİK
• Hasan NAZ
• Pınar KORKMAZ
• Tercan US

Hepatitis C Prevalence and Responses to Pegylated Interferon + Ribavirin Treatment Among Prisoners

• Hasan Selçuk ÖZGER
• Ömer KARAŞAHİN
• Mehmet Armağan TOY
• Sibel İBA YILMAZ
• Kenan HIZEL

Investigation of Antibody Responses in a Model of Hepatitis B Virus (HBV) Surface Antigen (HBsAg) and Specific Antibody Complex

• Resul KARAKUS
• Cemalettin AYBAY

Evaluation of Sustained Virological Response in Patients with Genotype 1b Chronic Hepatitis C Infection

• Esragül AKINCI
• Bircan ÜNAL KAYAASLAN
• Aliye TANRICI BAŞBUĞ
• Selim Sırrı EREN
• Pınar ÖNGÜRÜ
• Hürrem BODUR

Assessment of Patients with Hepatitis D

• Emine PARLAK
• Ayşe ERTÜRK
• Mehmet PARLAK
• Zahide KOŞAN
• Ayşe ALBAYRAK
• Zülal ÖZKURT
• Kemalettin ÖZDEN
• Serpil EROL

Skin Disease after Chronic Hepatitis C: Two Cases Report

• Yunus GÜRBÜZ
• Emin Ediz TÜTÜNCÜ
• Doğan Barış ÖZTÜRK
• Ayşe BAYLAK
• İrfan ŞENCAN

Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and PegylatedInterferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of ChronicHepatitis C Infection

• Şua SÜMER
• Onur URAL
• Nazlım AKTUĞDEMİR
• Gaye URAL
• Mehmet BALCI
• Nebahat DİKİCİ

The Distribution Clinical and Demographic Features of HBsAg Positive Patients in Sanliurfa Region

• Ahmet UYANIKOĞLU
• Umut SERT
• Burcu ÇETİN
• Hacer UYANIKOĞLU
• Necati YENİCE

Evaluation of Long-Term Follow-Up Results of the Patients with Anti-HDV Positivity

• Bahadir CEYLAN
• Muzaffer FINCANCI
• Cüneyt MÜDERRISOGLU
• Ferda SOYSAL
• Gülhan EREN

Waiting for Interferon-free Regimens for Chronic Hepatitis C Patients: A Multicenter Observational Study

• Rahmet Güner
• Zeliha Koçak Tufan
• Cemal Bulut
• Gülden Ersöz
• Ayşe Batırel
• Bahar Kaçmaz
• Bircan Kayaaslan
• Nurcan Baykam
• Alpay Arı
• Aziz Öğütlü
• Saygın Nayman Alpat
• Yasemin Durdu
• Özgür Günal
• Yunus Gürbüz
• Emsal Aydın
• Selma Tosun
• Fehmi Tabak
• Association to Combat Viral Hepatitis-Academic Camp Group

The Seroprevalence of and Risk Factors for Hepatitis B and C among Barbers and Hairdressers in tbe City Center of Sanliurfa

• İbrahim KORUK
• Süda TEKİN KORUK
• Bensu GÜRSOY
• Celal ÇALIŞIR
• Fehmi YÜKSEL
• Fadile YILDIZ ZEYREK
• Zeynep ŞİMŞEK

Interleukin 28B rs12979860 CT, rs12980275 GA, rs8099917 GT and TT genotypes are the Predictors of Rapid Viral Response in Hepatitis C Virus-Infected Patients

• Aydin RÜSTEMOĞLU
• Didem YALÇIN
• Özgür GÜNAL
• Betül ÇELİK
• Şener BARUT
• Ömer ATEŞ

The Factors Mfecting the Sustained Virological Response in Chronic Hepatitis C Treatment

• Yunus GÜRBÜZ
• Ediz TÜTÜNCÜ
• Barış ÖZTÜRK
• Ferit KUŞÇU
• İrfan ŞENCAN

Combination of Interferon Induction Therapy and Ribavirin in Chronic Hepatitis C Patients: Results of a Multicenter Clinical Trial

• Bilgehan AYGEN
• Orhan YILDIZ
• Rahmet ÇAYLAN
• Iftihar KÖKSAL
• Nese SALTOGLU
• Yesim TASOVA
• Hakan LEBLEBICIOGLU
• Saban ESEN

Case Report

Development of Acute Pancreatitis Due to Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis B: A Case Report

• Şükran KÖSE
• Melda TÜRKEN
• Mehmet TANRISEV
• Gülgün AKKOÇLU

Chronic Hepatitis C Treatment-Related Skin Rash: A Report of Two Cases

• Tuğba ARSLAN GÜLEN
• Ayfer İMRE

Psoriasis after Pegylated Interferon-Treatment of Chronic Hepatitis B Infection: Case Report

• Sezin AŞIK AKMAN
• Şükran KÖSE
• Oya HALICIOĞLU
• Ümit BAYOL
• Sibel ALPER

Pegylated Interferon Alpha-2b Associated Cutaneous Necrosis: A Case Report

• Rahmet GÜNER
• Derya YAPAR
• Murat SARICI
• Mehmet Akin TAŞYARAN

Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report

• Tugba SARI
• Suda Tekin KORUK
• Fatih TEMOÇIN

Partial Splenic Embolization may be an Option to Overcome Thrombocytopenia Interfering with Triple Therapy in HCV (+) Cirrhotic Patients: A Case Report

• Mehmet ASİL
• Murat BIYIK
• Sami ÇİFÇİ
• Serhat SAYIN
• Ramazan UÇAR
• Orhan ÖZBEK
• Hüseyin ATASEVEN
• Hakkı POLAT
• Ali DEMİR

Pegylated Interferon Alpha 2a Associated Dermatitis: A Case Report

• Saygın NAYMAN ALPAT
• Salih Atakan NEMLİ
• Nurettin ERBEN
• Elif DOYUK KARTAL
• İlhan ÖZGÜNEŞ
• Gaye USLUER

Sensorineural Hearing Loss Due to Pegylated Interferon Alfa/Ribavirin Therapy: A Case Report

• Tuğba SARI
• Süda TEKİN KORUK
• Alaaddin ZİREK

Koilonychia Developed in a Patient with Chronic Hepatitis B During Peginterferon Alfa-2a Treatment

• Aziz Öğütlü
• Hasan Tahsin Gözdaş
• Oğuz Karabay

Letter to the Editor

Paradoxes in Novel Hepatitis C Therapies: Is Combination of Sofosbuvir and Ribavirin Without Interferon Effective in Genotype 1b Chronic HCV Patients?

• Ergenekon KARAGÖZ
• Vedat TURHAN
• Asim ÜLÇAY
• Alpaslan TANOĞLU
• Hakan ERDEM

Letter to Editor

Seroprevalence Rates of Hepatitis B Surface Antigen, Anti-Hepatitis C Virus and Anti-Human Immunodeficiency Virus ½ Certain Risk Groups

• Tayfur DEMİRAY
• Kerem YILMAZ
• Mehmet KÖROĞLU
• Mustafa ALTINDİŞ

Other

Induction Therapy with Interferon-Alpha 2b in Naive Chronic Hepatitis C Patients

• Hakan LEBLEBICIOGLU
• Mustafa SÜNBÜL
• Bilgehan AYGEN
• Yasemin ERSOY
• Kemalettin AYDIN
• Ilyas DÖKMETAS

Prevalence of Isolated Anti-HBc in Manisa and Relation to Nonspesific Reactions

• Tamer SANLIDAG
• Sinem AKÇALI
• Sema ASKIN
• Cenk SEZGIN
• Beril ÖZBAKKALOGLU

KRONIK VIRAL HEPATIT TEDAVISINDE INTERFERONUN HEMATOLOJIK PARAMETRELERE ETKISI

• Dinç DINÇER
• Kadri DEMIR
• Sabahattin KAYMAKOGLU
• Yilmaz ÇAKALOGLU
• Fatih BESISIK
• Ziyaettin DURAKOGLU
• Salih TÜRKOGLU
• Selim BADUR
• Atilla ÖKTEN

SEROPREVALANCE OF HEPATITIS A IN SANLIURFA

• Gönül ASLAN
• Adnan SEYREK
• Akin ISCAN
• Eylem SEVINÇ
• Mustafa ULUKANLIGIL
• Murat BAKIR

CHRONIC HEPATIT C TREATMENT WITH INTERFERON ALPHA 2b-RIBAVIRIN COMBINATION THERAPY

• Ismail BALIK
• Osman MEMIKOGLU

COMPARISION OF ALPHA-INTERFERON MONOTHERAPY AND ALPHA-INTERFERON PLUS LAMIVUDINE COMBINATION FOR EFFICACY AND SAFETY IN CHRONIC HEPATITIS B

• Güven ÇELEBI
• Yunus GÜRBÜZ
• Rüçhan TÜRKYILMAZ

SEROPREVALANCE OF HBsAg, ANTI-HBs AND ANTI-HCV IN SANLIURFA

• Gönül ASLAN
• Mustafa ULUKANLIGIL
• Adnan SEYREK

Seroprevalence of HBV and HCV in Patients with Chronic Disease

• Irfan SENCAN
• Idris SAHIN
• Yasar SERTBAS
• Öner BALBAY
• Ismet BULUT

Case Report: Seconder Lung Tuberculosis Which Aggrevated During IFN-a Therapy

• Irfan SENCAN
• Mustafa YILDIRIM
• Peri Meram ARBAK

Long-Term Follow-Up of Hepatitis C Patients with Virological and Biochemical Response to Therapy and Investigation of Factors Predicting Relapses

• Bahadir CEYLAN
• Muzaffer FINCANCI
• Cüneyt MUDERRISOGLU
• Ferda SOYSAL
• Gülhan EREN

Effect of IFN-a2a Treatment Upon Serum IL-1ß, IL-6,TNF-aand Neopterin Levels in Patients with Chronic Viral Hepatitis B

• Mehmet YALNIZ
• Fulya ILHAN
• Hüseyin ATASEVEN
• Necip ILHAN
• I. Halil BAHÇECIOGLU

Treatment of Chronic Hepatitis C with Alpha Interferon in Hemodialysis Patients

• Fatih BESISIK
• Salih TÜRKOGLU
• Sabahattin KAYMAKOGLU
• Mürvet BOGAZCI
• Levent ERDEM
• Mehmet SEVER
• Alaattin YILDIZ
• Selim GÜREL
• Yilmaz ÇAKALOGLU
• Atilla ÖKTEN
• Selim BADUR

Evaluation of the Effectiveness of Interferon-Alpha and Lamivudine Combination Therapy inPatients with Chronic Hepatitis B Infection

• Tansu YAMAZHAN
• Bilgin ARDA
• Ekin ERTEM
• Sercan ULUSOY
• Demir SERTER

The Evaluation of Antiviral Therapy in Chronic Hepatitis B

• Özgür GÜNAL
• Kenan HIZEL
• Özlem GÜZEL
• Murat DIZBAY
• Fatma ULUTAN
• Dilek ARMAN

Evaluation of Thyroid Functions During Interferon-Alpha Treatment ofPatients with Chronic Viral Hepatitis

• Mustafa SÜNBÜL
• Ertan SAHBAT
• Mehmet AKKUS
• Saban ESEN
• Hakki KAHRAMAN
• Hakan LEBLEBICIOGLU

Interferon Alpha 2b Therapy in Acute Viral Hepatitis C:Two Years Followed Up of Seven Case

• Funda SIMSEK
• Fatma YÜKSEL
• Lütfü SAVAS

Prevalence of Hepatitis B Surface Antigen in Pregnant Women Attending to Obstetrics and Gynecology Department

• Ismail ÇEPNI
• Tugan BESE
• Mehmet ÇETINKAYA
• Altay GEZER
• Tarik ALTINOK

Alfa-Interferon Treatment in Children with Chronic Hepatitis B Virus Infection

• Sema AYDOGDU
• Erhun KASIRGA
• Ayse Mukadder SELIMOGLU
• Kaan KAVAKLI
• Tijen ÖZACAR
• Aysin ZEYTINOGLU
• Gül YÜCE
• Funda YILMAZ
• Rasit Vural YAGCI

Carriers of Hepatitis B Surface Antigen in Various Group

• Iclal BALCI
• Ilkay KARAOGLU
• Mehmet KARATAS

Hepatitis G Virus Infection and Chronic Liver Disease: Prevalence and The Effect on Clinical Findings and Interferon Therapy

• Atilla ÖKTEN
• Kadri DEMIR
• Mürvet BOZACI
• Sabahattin KAYMAKOGLU
• Salih TÜRKOGLU
• Selim BADUR
• Yilmaz ÇAKALOGLU

Interferon Therapy in the Chronic Hepatitis Due to Hepatitis B Virus

• Nafiz KOÇAK
• Sedat ÖZKÜÇÜK
• Hüsnü ALTUNAY
• M. Fevzi ÖZSOY
• Alaattin PAHSA
• Selim BADUR
• O. Sadi YENEN

Interferon Therapy in Chronic Hepatitis B Infection

• Yesim TASOVA
• Nese SALTOGLU
• Özlem ERDURAK
• Hasan S.Z. AKSU

A Case of Erythema Multiforme Related to Pegylated Interferon-a2a Plus Ribavirin Treatment for Chronic Hepatitis C Virus Infection

• Ilhan ÖZGÜNES
• Elif DOYUK KARTAL
• Nurettin ERBEN
• Saygin NAYMAN ALPAT
• Gaye USLUER

Recombinant Hepatitis B Vaccine and Recombinant Interferon + ? Combination Therapy in Chronic B Hepatitis

• Selim GÜREL
• Enver DOLAR
• Macit GÜLTEN
• S. Giray NAK
• Yusuf KARAASLAN

The Results of Interferon - ? and Lamivudine Combinotion Therapy in Non-Responder or Relapser Chronic Hepatitis B

• Selim GÜREL
• Enver DOLAR
• Macit GÜLTEN
• S. Giray NAK
• Yusuf KARAASLAN

Effects of Hygienic Conditions on HEV Seroprevalence in Hemodialysis Patients

• Irfan SENCAN
• Idris SAHIN
• Mustafa YILDIRIM
• Oguz KARABAY
• Davut ÖZDEMIR

THE EVALUATION OF INTRAERYTHROCYTE SUPEROXIDE DISMUTASE AND CATALASE ACTIVITY IN THE PATIENTS WITH HEPATITIS C INFECTION

• Aysun BAY KARABULUT
• Yasar BAYINDIR
• Çetin ÖZTÜRK
• Emine SÖNMEZ
• Kadir BATICIOGLU
• Engin GÖZÜKARA

ASSESSMENT OF HEPATITIS BAND C MARKERS IN CHRONIC HEMODIALYSIS PATIENTS

• Irfan SENCAN
• Idris SAHIN
• Necati ÇATAKOGLU
• Oguz ÜSKÜDAR
• Zeynep BAHTIYAR
• Mustafa YILDIRIM

THE SEROPREVALENCE OF HEPATITIS A, BAND C IN CHILDREN LIVING IN SANLIURFA CITY

• C.Dost ZEYREK
• Fadile YILDIZ ZEYREK
• Akin ISCAN
• Eylem SEVINÇ

HBV PREVALENCE OF BABIES IN ~ANLIURFA

• Gönül ASLAN
• Mansur TATLI
• Adnan SEYREK
• Mustafa ULUKANLIGIL
• Ali ATAS

FREQUENCIES OF HBsAg AND Anti-HCV MARKERS OF BlOOD DONORS FROM WEST BLACK SEA REGION

• Oguz KARABAY
• Irfan SENCAN
• Derya KAYAS
• Idris SAHIN

INTERFERON TREATMENT AND ITS RESULTS IN CHRONIC HEPATITIS 8

• Fatma SIRMATEL
• Mehmet CANDAN
• GönüI BAKIR
• Öcal SIRMATEL
• Kemal BAKIR